Therapeutic drug development program based on targeted protein degradation for novel coronavirus disease (COVID-19)
- Funded by Japan Agency for Medical Research and Development (AMED)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20202020Funder
Japan Agency for Medical Research and Development (AMED)Principal Investigator
Head. Tsuyoshi NAGASEResearch Location
JapanLead Research Institution
Medicinal Chemistry Research Laboratories, Department of New Drug Research Division, Otsuka Pharmaceutical Co., Ltd.Research Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable